Loading...
HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance
The introduction of anti-HER2 therapies to the treatment of patients with HER2-positive breast cancer has led to dramatic improvements in survival in both early and advanced settings. Despite this breakthrough, nearly all patients with metastatic HER2-positive breast cancer eventually progress on an...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6425535/ https://ncbi.nlm.nih.gov/pubmed/30911337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919833519 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|